Alex A. Adjei is Chairman of the Taussig Cancer Institute and the M. Frank Rudy and Margaret D. Rudy Distinguished Chair in Translational Cancer Research at Cleveland Clinic. He received the first American Society of Clinical Oncology Drug Development Research Professorship 2012-2017, in recognition of his mentorship and work in cancer drug development. He also received the International Association for the Study of Lung Cancer Award for Distinguished Service in Lung Cancer Research and Mentorship, and the European Society of Medical Oncology Lifetime Achievement Award, in 2020 and 2021 respectively. Dr Adjei’s research is focused on experimental therapeutics, regulatory science and clinical drug development. He is editor-in-chief of the Journal of Thoracic Oncology, and the JTO Clinical and Research Reports, and has authored over 300 peer-reviewed publications.